Skip to main content
Top
Published in: Tumor Biology 2/2014

01-02-2014 | Research Article

Antitumor effect of fructose 1,6-bisphosphate and its mechanism in hepatocellular carcinoma cells

Authors: Yin-Xiang Lu, Xi-Can Yu, Mei-Ying Zhu

Published in: Tumor Biology | Issue 2/2014

Login to get access

Abstract

We aimed to investigate the antitumor effect and mechanism of fructose 1,6-bisphosphate (F1,6BP) in a hepatocellular carcinoma cell line. HepG2 cells were treated with different concentrations of F1,6BP alone or in combination with antioxidant N-acetyl-l-cysteine (NAC) or catalase (CAT), and cell proliferation assays were performed. Nuclear morphology was observed by fluorescence microscopy after Hoechst staining, and apoptosis was measured with flow cytometry. Changes in reactive oxygen species (ROS) levels in HepG2 cells were detected by 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) staining. A colorimetric assay was adopted to determine the percentage of oxidized glutathione in these cells. CAT and glutathione peroxidase (GSH-Px) mRNA expression levels in HepG2 cells were measured by real-time fluorescence quantitative PCR. HepG2 cell proliferation was significantly inhibited by F1,6BP, accompanied by an increase in intracellular ROS levels and oxidized glutathione. Upregulated apoptosis and characteristic nuclear morphological changes were observed, and the expression of CAT and GSH-Px mRNA was increased after F1,6BP treatment. The antitumor effect of F1,6BP was significantly decreased after pretreatment with NAC and CAT in HepG2 cells. In conclusion, F1,6BP can induce the apoptosis of HepG2 cells. The mechanism involved may be associated with the generation of ROS, especially the production of H2O2.
Literature
1.
go back to reference Han DJ, Kim JB, Park SY, et al. Growth inhibition of hepatocellular carcinoma Huh7 cells by Lactobacillus casei extract. Yonsei Med J. 2013;54:1186–93.PubMedCentralPubMedCrossRef Han DJ, Kim JB, Park SY, et al. Growth inhibition of hepatocellular carcinoma Huh7 cells by Lactobacillus casei extract. Yonsei Med J. 2013;54:1186–93.PubMedCentralPubMedCrossRef
2.
go back to reference Jihye C, Jinsil S, Lee IJ, et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013;54(5):1178–85.CrossRef Jihye C, Jinsil S, Lee IJ, et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013;54(5):1178–85.CrossRef
3.
go back to reference Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol. 2008;23:467–73.PubMedCrossRef Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol. 2008;23:467–73.PubMedCrossRef
4.
go back to reference Nel I, Baba HA, Ertle J, et al. Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol. 2013;6(4):420–8.PubMedCentralPubMed Nel I, Baba HA, Ertle J, et al. Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma. Transl Oncol. 2013;6(4):420–8.PubMedCentralPubMed
5.
go back to reference De Raedt T, Walton Z, Yecies JL, et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 2011;20(3):400–13.PubMedCentralPubMedCrossRef De Raedt T, Walton Z, Yecies JL, et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 2011;20(3):400–13.PubMedCentralPubMedCrossRef
6.
go back to reference Mauro C, Leow SC, Anso E, et al. NF-κB controls energy homeostasis and metabolic adaptation by up-regulating mitochondrial respiration. Nat Cell Biol. 2011;13(10):1272–9.PubMedCentralPubMedCrossRef Mauro C, Leow SC, Anso E, et al. NF-κB controls energy homeostasis and metabolic adaptation by up-regulating mitochondrial respiration. Nat Cell Biol. 2011;13(10):1272–9.PubMedCentralPubMedCrossRef
7.
go back to reference Lian XY, Khan FA, Stringer JL. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J Neurosci. 2007;27(44):12007–11.PubMedCrossRef Lian XY, Khan FA, Stringer JL. Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J Neurosci. 2007;27(44):12007–11.PubMedCrossRef
8.
go back to reference Gourlay CW, Ayscough KR. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J Cell Sci. 2005;118(Pt 10):2119–32.PubMedCrossRef Gourlay CW, Ayscough KR. Identification of an upstream regulatory pathway controlling actin-mediated apoptosis in yeast. J Cell Sci. 2005;118(Pt 10):2119–32.PubMedCrossRef
9.
go back to reference Debnath T, Park SR, da Kim H, et al. Anti-oxidant and anti-inflammatory activities of inonotus obliquus and germinated brown rice extracts. Molecules. 2013;18(8):9293–304.PubMedCrossRef Debnath T, Park SR, da Kim H, et al. Anti-oxidant and anti-inflammatory activities of inonotus obliquus and germinated brown rice extracts. Molecules. 2013;18(8):9293–304.PubMedCrossRef
10.
go back to reference Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10(3):175–6.PubMedCrossRef Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10(3):175–6.PubMedCrossRef
11.
go back to reference Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10(3):241–52.PubMedCrossRef Trachootham D, Zhou Y, Zhang H, et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 2006;10(3):241–52.PubMedCrossRef
12.
go back to reference Chen W, Zhao Z, Li L, et al. Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway. Free Radio Biol Med. 2008;45(1):60–72.CrossRef Chen W, Zhao Z, Li L, et al. Hispolon induces apoptosis in human gastric cancer cells through a ROS-mediated mitochondrial pathway. Free Radio Biol Med. 2008;45(1):60–72.CrossRef
13.
go back to reference Kim AD, Kang KA, Kim HS, et al. A ginseng metabolite, compound K, induces artophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis. 2013;4:e750.PubMedCentralPubMedCrossRef Kim AD, Kang KA, Kim HS, et al. A ginseng metabolite, compound K, induces artophagy and apoptosis via generation of reactive oxygen species and activation of JNK in human colon cancer cells. Cell Death Dis. 2013;4:e750.PubMedCentralPubMedCrossRef
14.
go back to reference Rasul A, Di J, Millimouno FM, et al. Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. Molecules. 2013;18(8):9382–96.PubMedCrossRef Rasul A, Di J, Millimouno FM, et al. Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells. Molecules. 2013;18(8):9382–96.PubMedCrossRef
15.
16.
go back to reference Cuesta E, Boada J, Calafell R, et al. Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by d-galactosamine in rats. Crit Care Med. 2006;34(3):807–14.PubMed Cuesta E, Boada J, Calafell R, et al. Fructose 1,6-bisphosphate prevented endotoxemia, macrophage activation, and liver injury induced by d-galactosamine in rats. Crit Care Med. 2006;34(3):807–14.PubMed
17.
go back to reference Alva N, Cruz D, Sanchez S, et al. Nitric oxide as a mediator of fructose 1,6-bisphosphate protection in galactosamine-induced hepatotoxicity in rats. Nitric Oxide. 2013;28:17–23.PubMedCrossRef Alva N, Cruz D, Sanchez S, et al. Nitric oxide as a mediator of fructose 1,6-bisphosphate protection in galactosamine-induced hepatotoxicity in rats. Nitric Oxide. 2013;28:17–23.PubMedCrossRef
18.
go back to reference Burlacu A, Jinga V, Gafencu AV, et al. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res. 2001;306(3):409–16.PubMedCrossRef Burlacu A, Jinga V, Gafencu AV, et al. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res. 2001;306(3):409–16.PubMedCrossRef
Metadata
Title
Antitumor effect of fructose 1,6-bisphosphate and its mechanism in hepatocellular carcinoma cells
Authors
Yin-Xiang Lu
Xi-Can Yu
Mei-Ying Zhu
Publication date
01-02-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1231-z

Other articles of this Issue 2/2014

Tumor Biology 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine